<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37240370</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24109022</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is manifested as skeletal muscle denervation, loss of motor neurons and finally severe respiratory failure. Mutations of RNA-binding protein FUS are one of the common genetic reasons of ALS accompanied by a 'dying back' type of degeneration. Using fluorescent approaches and microelectrode recordings, the early structural and functional alterations in diaphragm neuromuscular junctions (NMJs) were studied in mutant FUS mice at the pre-onset stage. Lipid peroxidation and decreased staining with a lipid raft marker were found in the mutant mice. Despite the preservation of the end-plate structure, immunolabeling revealed an increase in levels of presynaptic proteins, SNAP-25 and synapsin 1. The latter can restrain Ca<sup>2+</sup>-dependent synaptic vesicle mobilization. Indeed, neurotransmitter release upon intense nerve stimulation and its recovery after tetanus and compensatory synaptic vesicle endocytosis were markedly depressed in FUS mice. There was a trend to attenuation of axonal [Ca<sup>2+</sup>]<sub>in</sub> increase upon nerve stimulation at 20 Hz. However, no changes in neurotransmitter release and the intraterminal Ca<sup>2+</sup> transient in response to low frequency stimulation or in quantal content and the synchrony of neurotransmitter release at low levels of external Ca<sup>2+</sup> were detected. At a later stage, shrinking and fragmentation of end plates together with a decrease in presynaptic protein expression and disturbance of the neurotransmitter release timing occurred. Overall, suppression of synaptic vesicle exo-endocytosis upon intense activity probably due to alterations in membrane properties, synapsin 1 levels and Ca<sup>2+</sup> kinetics could be an early sign of nascent NMJ pathology, which leads to neuromuscular contact disorganization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mukhamedyarov</LastName><ForeName>Marat A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khabibrakhmanov</LastName><ForeName>Aydar N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-5625-8658</Identifier><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khuzakhmetova</LastName><ForeName>Venera F</ForeName><Initials>VF</Initials><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giniatullin</LastName><ForeName>Arthur R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0003-4789-1800</Identifier><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakirjanova</LastName><ForeName>Guzalia F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhilyakov</LastName><ForeName>Nikita V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhutdinova</LastName><ForeName>Kamilla A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samigullin</LastName><ForeName>Dmitry V</ForeName><Initials>DV</Initials><Identifier Source="ORCID">0000-0001-6019-5514</Identifier><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiophotonics and Microwave Technologies, Kazan National Research Technical University, 10 K. Marx St., Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigoryev</LastName><ForeName>Pavel N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakharov</LastName><ForeName>Andrey V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Kazan Federal University, Kazan 420008, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zefirov</LastName><ForeName>Andrey L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrov</LastName><ForeName>Alexey M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-1432-3455</Identifier><AffiliationInfo><Affiliation>Department of Normal Physiology, Kazan State Medial University, 49 Butlerova St., Kazan 420012, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kazan Institute of Biochemistry and Biophysics, Federal Research Center ''Kazan Scientific Center of RAS", 2/31 Lobachevsky St., P.O. Box 30, Kazan 420111, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>21-14-00044</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant><Grant><GrantID>contract 1/22-3 dated July 13, 2022</GrantID><Agency>Kazan State Medical University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016704">Synapsins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018377">Neurotransmitter Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016704" MajorTopicYN="N">Synapsins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018377" MajorTopicYN="N">Neurotransmitter Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">asynchronous neurotransmitter release</Keyword><Keyword MajorTopicYN="N">calcium transient</Keyword><Keyword MajorTopicYN="N">end plate</Keyword><Keyword MajorTopicYN="N">endocytosis</Keyword><Keyword MajorTopicYN="N">exocytosis</Keyword><Keyword MajorTopicYN="N">neuromuscular junction (NMJ)</Keyword><Keyword MajorTopicYN="N">nicotinic acetylcholine receptor (nAChR)</Keyword><Keyword MajorTopicYN="N">synapsin</Keyword><Keyword MajorTopicYN="N">synaptic vesicle</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37240370</ArticleId><ArticleId IdType="pmc">PMC10218837</ArticleId><ArticleId IdType="doi">10.3390/ijms24109022</ArticleId><ArticleId IdType="pii">ijms24109022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo X., Smith V., Jackson M., Tran M., Thomas M., Patel A., Lorusso E., Nimbalkar S., Cai Y., McAleer C.W., et al. A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing. Adv. Ther. 2020;3:2000133. doi: 10.1002/adtp.202000133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adtp.202000133</ArticleId><ArticleId IdType="pmc">PMC7942691</ArticleId><ArticleId IdType="pubmed">33709015</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhindi A., Boehm I., Chaytow H. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS) J. Anat. 2022;241:1089&#x2013;1107. doi: 10.1111/joa.13463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.13463</ArticleId><ArticleId IdType="pmc">PMC9558162</ArticleId><ArticleId IdType="pubmed">34101196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>So E., Mitchell J.C., Memmi C., Chennell G., Vizcay-Barrena G., Allison L., Shaw C.E., Vance C. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Hum. Mol. Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelon P.A., Dutchak P.A., Sephton C.F. Synaptic dysfunction in ALS and FTD: Anatomical and molecular changes provide insights into mechanisms of disease. Front. Mol. Neurosci. 2022;15:1000183. doi: 10.3389/fnmol.2022.1000183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.1000183</ArticleId><ArticleId IdType="pmc">PMC9575515</ArticleId><ArticleId IdType="pubmed">36263379</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G., Demestre M., Zuko A., Been M., Higelin J., Dieterle S., Goy M.A., Mallik M., Sellier C., Scekic-Zahirovic J., et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci. 2019;22:1793&#x2013;1805. doi: 10.1038/s41593-019-0498-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0498-9</ArticleId><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., Khurana S., Vats A., Sahu B., Ganguly N.K., Chakraborti P., Gourie-Devi M., Taneja V. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2022;59:1502&#x2013;1527. doi: 10.1007/s12035-021-02658-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02658-6</ArticleId><ArticleId IdType="pubmed">34997540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhamedyarov M.A., Petrov A.M., Grigoryev P.N., Giniatullin A.R., Petukhova E.O., Zefirov A.L. Amyotrophic Lateral Sclerosis: Modern Views on the Pathogenesis and Experimental Models. Zhurnal Vyss. Nervn. Deyatelnosti Im. IP Pavlov. 2018;68:551&#x2013;566. doi: 10.1134/s0044467718050106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/s0044467718050106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Rev. Neurol. 2021;177:333&#x2013;340. doi: 10.1016/j.neurol.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.06.010</ArticleId><ArticleId IdType="pubmed">33036763</ArticleId></ArticleIdList></Reference><Reference><Citation>Assoni A.F., Foijer F., Zatz M. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects. Stem Cell Rev. Rep. 2023;19:625&#x2013;638. doi: 10.1007/s12015-022-10489-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10489-8</ArticleId><ArticleId IdType="pubmed">36515764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 2005;15:587&#x2013;593. doi: 10.1016/j.cub.2005.01.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.01.058</ArticleId><ArticleId IdType="pubmed">15797031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Salam S., Tacconelli S., Smith B.N., Mitchell J.C., Glennon E., Nikolaou N., Houart C., Vance C. Identification of a novel interaction of FUS and syntaphilin may explain synaptic and mitochondrial abnormalities caused by ALS mutations. Sci. Rep. 2021;11:13613. doi: 10.1038/s41598-021-93189-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93189-6</ArticleId><ArticleId IdType="pmc">PMC8245466</ArticleId><ArticleId IdType="pubmed">34193962</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K., Krasnow E.N., Fumagalli L., Vandoorne T., Baatsen P., Kerstens A., Giacomazzi G., Pavie B., Rossaert E., Beckers J., et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep. 2021;16:2213&#x2013;2227. doi: 10.1016/j.stemcr.2021.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC8452598</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 2000;3:661&#x2013;669. doi: 10.1038/76615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76615</ArticleId><ArticleId IdType="pubmed">10862698</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M.J., Sieck G.C. Evolution and Functional Differentiation of the Diaphragm Muscle of Mammals. Compr. Physiol. 2019;9:715&#x2013;766. doi: 10.1002/cphy.c180012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c180012</ArticleId><ArticleId IdType="pmc">PMC7082849</ArticleId><ArticleId IdType="pubmed">30873594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieck D.C., Zhan W.Z., Fang Y.H., Ermilov L.G., Sieck G.C., Mantilla C.B. Structure-activity relationships in rodent diaphragm muscle fibers vs. neuromuscular junctions. Respir. Physiol. Neurobiol. 2012;180:88&#x2013;96. doi: 10.1016/j.resp.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2011.10.015</ArticleId><ArticleId IdType="pmc">PMC3242937</ArticleId><ArticleId IdType="pubmed">22063925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebastiao A.M., Ribeiro J.A. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS ONE. 2013;8:e73846. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakyrjanova G.F., Giniatullin A.R., Mukhutdinova K.A., Kuznetsova E.A., Petrov A.M. Early differences in membrane properties at the neuromuscular junctions of ALS model mice: Effects of 25-hydroxycholesterol. Life Sci. 2021;273:119300. doi: 10.1016/j.lfs.2021.119300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119300</ArticleId><ArticleId IdType="pubmed">33662433</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento F., Sebastiao A.M., Ribeiro J.A. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission. Purinergic Signal. 2015;11:471&#x2013;480. doi: 10.1007/s11302-015-9465-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-015-9465-4</ArticleId><ArticleId IdType="pmc">PMC4648802</ArticleId><ArticleId IdType="pubmed">26335190</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D., Tremblay E., Martineau E., Julien J.P., Robitaille R. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J. Neurosci. 2015;35:688&#x2013;706. doi: 10.1523/JNEUROSCI.1379-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., Li A., Li X., Park K., Zhou X., Yi F., Xiao Y., Yoon D., Tan T., Ostrow L.W., et al. MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression. Antioxidants. 2021;10:1522. doi: 10.3390/antiox10101522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10101522</ArticleId><ArticleId IdType="pmc">PMC8532806</ArticleId><ArticleId IdType="pubmed">34679657</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Peters O.M., Deykin A.V., Connor-Robson N., Robinson H., Ustyugov A.A., Bachurin S.O., Ermolkevich T.G., Goldman I.L., Sadchikova E.R., et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J. Biol. Chem. 2013;288:25266&#x2013;25274. doi: 10.1074/jbc.M113.492017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.492017</ArticleId><ArticleId IdType="pmc">PMC3757190</ArticleId><ArticleId IdType="pubmed">23867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Funikov S.Y., Rezvykh A.P., Mazin P.V., Morozov A.V., Maltsev A.V., Chicheva M.M., Vikhareva E.A., Evgen&#x2019;ev M.B., Ustyugov A.A. FUS(1-359) transgenic mice as a model of ALS: Pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018;19:189&#x2013;204. doi: 10.1007/s10048-018-0553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-018-0553-9</ArticleId><ArticleId IdType="pubmed">29982879</ArticleId></ArticleIdList></Reference><Reference><Citation>Probert F., Gorlova A., Deikin A., Bettendorff L., Veniaminova E., Nedorubov A., Chaprov K.D., Ivanova T.A., Anthony D.C., Strekalova T. In FUS [1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome. Biomed. Pharmacother. 2022;156:113986. doi: 10.1016/j.biopha.2022.113986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113986</ArticleId><ArticleId IdType="pubmed">36411653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambon M., Gorlova A., Demelenne A., Alhama-Riba J., Coumans B., Lakaye B., Wins P., Fillet M., Anthony D.C., Strekalova T., et al. Dibenzoylthiamine Has Powerful Antioxidant and Anti-Inflammatory Properties in Cultured Cells and in Mouse Models of Stress and Neurodegeneration. Biomedicines. 2020;8:361. doi: 10.3390/biomedicines8090361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8090361</ArticleId><ArticleId IdType="pmc">PMC7555733</ArticleId><ArticleId IdType="pubmed">32962139</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivello M., Hogg M.C., Jirstrom E., Halang L., Woods I., Rayner M., Coughlan K.S., Lewandowski S.A., Prehn J.H.M. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model. Dis. Model. Mech. 2019;12:dmm040238. doi: 10.1242/dmm.040238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.040238</ArticleId><ArticleId IdType="pmc">PMC6737946</ArticleId><ArticleId IdType="pubmed">31383794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lysikova E.A., Kukharsky M.S., Chaprov K.D., Vasilieva N.A., Roman A.Y., Ovchinnikov R.K., Deykin A.V., Ninkina N., Buchman V.L. Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration. Genes Brain Behav. 2019;18:e12607. doi: 10.1111/gbb.12607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12607</ArticleId><ArticleId IdType="pubmed">31437340</ArticleId></ArticleIdList></Reference><Reference><Citation>de Munter J., Shafarevich I., Liundup A., Pavlov D., Wolters E.C., Gorlova A., Veniaminova E., Umriukhin A., Kalueff A., Svistunov A., et al. Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice. CNS Neurosci. Ther. 2020;26:504&#x2013;517. doi: 10.1111/cns.13280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13280</ArticleId><ArticleId IdType="pmc">PMC7163689</ArticleId><ArticleId IdType="pubmed">31867846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg M.C., Halang L., Woods I., Coughlan K.S., Prehn J.H.M. Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotroph. Lateral Scler. Front. Degener. 2018;19:438&#x2013;445. doi: 10.1080/21678421.2017.1407796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407796</ArticleId><ArticleId IdType="pubmed">29221425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J., Strom A.L., Kilty R., Venkatakrishnan P., White J., Everson W.V., Smart E.J., Zhu H. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J. 2009;276:3308&#x2013;3323. doi: 10.1111/j.1742-4658.2009.07057.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07057.x</ArticleId><ArticleId IdType="pmc">PMC2754564</ArticleId><ArticleId IdType="pubmed">19438725</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Beltran L.C., Godoy-Corchuelo J.M., Losa-Fontangordo M., Williams D., Matias-Guiu J., Corrochano S. A Transcriptomic Meta-Analysis Shows Lipid Metabolism Dysregulation as an Early Pathological Mechanism in the Spinal Cord of SOD1 Mice. Int. J. Mol. Sci. 2021;22:9553. doi: 10.3390/ijms22179553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179553</ArticleId><ArticleId IdType="pmc">PMC8431303</ArticleId><ArticleId IdType="pubmed">34502460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouscary A., Quessada C., Mosbach A., Callizot N., Spedding M., Loeffler J.P., Henriques A. Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. Front. Pharmacol. 2019;10:883. doi: 10.3389/fphar.2019.00883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00883</ArticleId><ArticleId IdType="pmc">PMC6692493</ArticleId><ArticleId IdType="pubmed">31447678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Ichinomiya T., Savchenko P., Wang D., Sawada A., Li X., Duong T., Li W., Bonds J.A., Kim E.J., et al. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (AAV9-SynCav1) preserves motor neuron and neuromuscular junction morphology, motor function, delays disease onset, and extends survival in hSOD1(G93A) mice. Theranostics. 2022;12:5389&#x2013;5403. doi: 10.7150/thno.72614.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.72614</ArticleId><ArticleId IdType="pmc">PMC9330519</ArticleId><ArticleId IdType="pubmed">35910808</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada A., Wang S., Jian M., Leem J., Wackerbarth J., Egawa J., Schilling J.M., Platoshyn O., Zemljic-Harpf A., Roth D.M., et al. Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1(G93A) mice. FASEB J. 2019;33:7545&#x2013;7554. doi: 10.1096/fj.201802652RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802652RR</ArticleId><ArticleId IdType="pmc">PMC6529340</ArticleId><ArticleId IdType="pubmed">30894019</ArticleId></ArticleIdList></Reference><Reference><Citation>DiPasquale M., Deering T.G., Desai D., Sharma A.K., Amin S., Fox T.E., Kester M., Katsaras J., Marquardt D., Heberle F.A. Influence of ceramide on lipid domain stability studied with small-angle neutron scattering: The role of acyl chain length and unsaturation. Chem. Phys. Lipids. 2022;245:105205. doi: 10.1016/j.chemphyslip.2022.105205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemphyslip.2022.105205</ArticleId><ArticleId IdType="pmc">PMC9320172</ArticleId><ArticleId IdType="pubmed">35483419</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsentsevitsky A.N., Gafurova C.R., Mukhutdinova K.A., Giniatullin A.R., Fedorov N.S., Malomouzh A.I., Petrov A.M. Sphingomyelinase modulates synaptic vesicle mobilization at the mice neuromuscular junctions. Life Sci. 2023;318:121507. doi: 10.1016/j.lfs.2023.121507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2023.121507</ArticleId><ArticleId IdType="pubmed">36801470</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov A.M., Shalagina M.N., Protopopov V.A., Sergeev V.G., Ovechkin S.V., Ovchinina N.G., Sekunov A.V., Zefirov A.L., Zakirjanova G.F., Bryndina I.G. Changes in Membrane Ceramide Pools in Rat Soleus Muscle in Response to Short-Term Disuse. Int. J. Mol. Sci. 2019;20:4860. doi: 10.3390/ijms20194860.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20194860</ArticleId><ArticleId IdType="pmc">PMC6801848</ArticleId><ArticleId IdType="pubmed">31574943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsentsevitsky A.N., Gafurova C.R., Petrov A.M. K(ATP) channels as ROS-dependent modulator of neurotransmitter release at the neuromuscular junctions. Life Sci. 2022;310:121120. doi: 10.1016/j.lfs.2022.121120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.121120</ArticleId><ArticleId IdType="pubmed">36302500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsentsevitsky A.N., Zakyrjanova G.F., Petrov A.M. Cadmium desynchronizes neurotransmitter release in the neuromuscular junction: Key role of ROS. Free. Radic. Biol. Med. 2020;155:19&#x2013;28. doi: 10.1016/j.freeradbiomed.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.05.017</ArticleId><ArticleId IdType="pubmed">32445865</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuzakhmetova V., Samigullin D., Nurullin L., Vyskocil F., Nikolsky E., Bukharaeva E. Kinetics of neurotransmitter release in neuromuscular synapses of newborn and adult rats. Int. J. Dev. Neurosci. 2014;34:9&#x2013;18. doi: 10.1016/j.ijdevneu.2013.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2013.12.010</ArticleId><ArticleId IdType="pubmed">24412779</ArticleId></ArticleIdList></Reference><Reference><Citation>McLachlan E.M. The statistics of transmitter release at chemical synapses. Int. Rev. Physiol. 1978;17:49&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">29846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsentsevitsky A.N., Khaziev E.F., Kovyazina I.V., Petrov A.M. GIRK channel as a versatile regulator of neurotransmitter release via L-type Ca2+ channel-dependent mechanism in the neuromuscular junction. Neuropharmacology. 2022;209:109021. doi: 10.1016/j.neuropharm.2022.109021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2022.109021</ArticleId><ArticleId IdType="pubmed">35245509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukharaeva E.A., Skorinkin A.I., Samigullin D.V., Petrov A.M. Presynaptic Acetylcholine Receptors Modulate the Time Course of Action Potential-Evoked Acetylcholine Quanta Secretion at Neuromuscular Junctions. Biomedicines. 2022;10:1771. doi: 10.3390/biomedicines10081771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10081771</ArticleId><ArticleId IdType="pmc">PMC9332499</ArticleId><ArticleId IdType="pubmed">35892671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginebaugh S.P., Badawi Y., Tarr T.B., Meriney S.D. Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States. Biomolecules. 2022;12:740. doi: 10.3390/biom12060740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12060740</ArticleId><ArticleId IdType="pmc">PMC9221282</ArticleId><ArticleId IdType="pubmed">35740866</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi F., Fucile S. Calcium influx through muscle nAChR-channels: One route, multiple roles. Neuroscience. 2020;439:117&#x2013;124. doi: 10.1016/j.neuroscience.2019.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2019.04.011</ArticleId><ArticleId IdType="pubmed">30999028</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackman S.L., Regehr W.G. The Mechanisms and Functions of Synaptic Facilitation. Neuron. 2017;94:447&#x2013;464. doi: 10.1016/j.neuron.2017.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.047</ArticleId><ArticleId IdType="pmc">PMC5865607</ArticleId><ArticleId IdType="pubmed">28472650</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Moreno A., Henriquez J.P. Maturation of a postsynaptic domain: Role of small Rho GTPases in organising nicotinic acetylcholine receptor aggregates at the vertebrate neuromuscular junction. J. Anat. 2022;241:1148&#x2013;1156. doi: 10.1111/joa.13526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.13526</ArticleId><ArticleId IdType="pmc">PMC9558164</ArticleId><ArticleId IdType="pubmed">34342888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolf R., Straka T. Nicotinic acetylcholine receptor at vertebrate motor endplates: Endocytosis, recycling, and degradation. Neurosci. Lett. 2019;711:134434. doi: 10.1016/j.neulet.2019.134434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134434</ArticleId><ArticleId IdType="pubmed">31421156</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall L., Duddy W.J., Martinat C., Mariot V., Connolly O., Milla V., Anakor E., Ouandaogo Z.G., Millecamps S., Laine J., et al. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. J. Cachexia Sarcopenia Muscle. 2022;13:1385&#x2013;1402. doi: 10.1002/jcsm.12945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12945</ArticleId><ArticleId IdType="pmc">PMC8978001</ArticleId><ArticleId IdType="pubmed">35194965</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli C., Sharma P., Zonefrati R., Palmini G., Lucattelli E., Ward D.T., Ellinger I., Innocenti M., Brandi M.L. Study of the Expression and Function of Calcium-Sensing Receptor in Human Skeletal Muscle. Int. J. Mol. Sci. 2021;22:7282. doi: 10.3390/ijms22147282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147282</ArticleId><ArticleId IdType="pmc">PMC8304165</ArticleId><ArticleId IdType="pubmed">34298895</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpe P., Bosutti A., Nori A., Filadi R., Gherardi G., Trautmann G., Furlan S., Massaria G., Sciancalepore M., Megighian A., et al. Nerve-dependent distribution of subsynaptic type 1 inositol 1,4,5-trisphosphate receptor at the neuromuscular junction. J. Gen. Physiol. 2022;154:e202213128. doi: 10.1085/jgp.202213128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1085/jgp.202213128</ArticleId><ArticleId IdType="pmc">PMC9513380</ArticleId><ArticleId IdType="pubmed">36149386</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahadevan S., Hembach K.M., Tantardini E., Perez-Berlanga M., Hruska-Plochan M., Megat S., Weber J., Schwarz P., Dupuis L., Robinson M.D., et al. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. Nat. Commun. 2021;12:3027. doi: 10.1038/s41467-021-23188-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23188-8</ArticleId><ArticleId IdType="pmc">PMC8140117</ArticleId><ArticleId IdType="pubmed">34021139</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansevrino R., Hoffmann C., Milovanovic D. Condensate biology of synaptic vesicle clusters. Trends Neurosci. 2023;46:293&#x2013;306. doi: 10.1016/j.tins.2023.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2023.01.001</ArticleId><ArticleId IdType="pubmed">36725404</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert S.M., Skoruppa M., Yu B., Mulcahy B., Zhen M., Gao S., Sendtner M., Stigloher C. Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission. Biol. Open. 2020;9:bio055129. doi: 10.1242/bio.055129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.055129</ArticleId><ArticleId IdType="pmc">PMC7746668</ArticleId><ArticleId IdType="pubmed">33148607</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Lorenzini I., Chou C.C., Torvund M., Rogers R.S., Starr A., Zaepfel B.L., Levy J., Johannesmeyer J., Schwartz J.C., et al. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS. Cell. Rep. 2017;21:110&#x2013;125. doi: 10.1016/j.celrep.2017.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan M., Gopaul K.R., Miry O., Hokfelt T., Stanton P.K., Bark C. SNAP-25 isoforms differentially regulate synaptic transmission and long-term synaptic plasticity at central synapses. Sci. Rep. 2019;9:6403. doi: 10.1038/s41598-019-42833-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42833-3</ArticleId><ArticleId IdType="pmc">PMC6484009</ArticleId><ArticleId IdType="pubmed">31024034</ArticleId></ArticleIdList></Reference><Reference><Citation>Scullin C.S., Tafoya L.C., Wilson M.C., Partridge L.D. Presynaptic residual calcium and synaptic facilitation at hippocampal synapses of mice with altered expression of SNAP-25. Brain Res. 2012;1431:1&#x2013;12. doi: 10.1016/j.brainres.2011.10.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.10.035</ArticleId><ArticleId IdType="pmc">PMC3246534</ArticleId><ArticleId IdType="pubmed">22119397</ArticleId></ArticleIdList></Reference><Reference><Citation>Feliciano P., Matos H., Andrade R., Bykhovskaia M. Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype. J. Neurosci. 2017;37:1757&#x2013;1771. doi: 10.1523/JNEUROSCI.0844-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0844-16.2016</ArticleId><ArticleId IdType="pmc">PMC5320607</ArticleId><ArticleId IdType="pubmed">28087765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Augustine G.J. Synapsins and the Synaptic Vesicle Reserve Pool: Floats or Anchors? Cells. 2021;10:658. doi: 10.3390/cells10030658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030658</ArticleId><ArticleId IdType="pmc">PMC8002314</ArticleId><ArticleId IdType="pubmed">33809712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaden J.H., Banumurthy G., Gusarevich E.S., Overstreet-Wadiche L., Wadiche J.I. The readily-releasable pool dynamically regulates multivesicular release. Elife. 2019;8:e47434. doi: 10.7554/eLife.47434.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47434</ArticleId><ArticleId IdType="pmc">PMC6716946</ArticleId><ArticleId IdType="pubmed">31364987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv J., Xiao X., Bi M., Tang T., Kong D., Diao M., Jiao Q., Chen X., Yan C., Du X., et al. ATP-sensitive potassium channels: A double-edged sword in neurodegenerative diseases. Ageing Res. Rev. 2022;80:101676. doi: 10.1016/j.arr.2022.101676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101676</ArticleId><ArticleId IdType="pubmed">35724860</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K., Terrie L., Baatsen P., Kerstens A., De Swert L., Janky R., Corthout N., Masrori P., Van Damme P., Hyttel P., et al. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Mol. Neurodegener. 2023;18:5. doi: 10.1186/s13024-022-00591-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00591-3</ArticleId><ArticleId IdType="pmc">PMC9847053</ArticleId><ArticleId IdType="pubmed">36653804</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidullah M., Le Marchand S.J., Fei H., Zhang J., Pandey U.B., Dalva M.B., Pasinelli P., Levitan I.B. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. J. Neurosci. 2013;33:19590&#x2013;19598. doi: 10.1523/JNEUROSCI.3396-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId><ArticleId IdType="pmc">PMC3858628</ArticleId><ArticleId IdType="pubmed">24336723</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse van Mantgem M.R., van Rheenen W., Hackeng A.V., van Es M.A., Veldink J.H., van den Berg L.H., van Eijk R.P.A. Association between Serum Lipids and Survival in Patients with Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study. Neurology. 2023;100:e1062&#x2013;e1071. doi: 10.1212/WNL.0000000000201657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000201657</ArticleId><ArticleId IdType="pmc">PMC9990853</ArticleId><ArticleId IdType="pubmed">36460467</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal I., Lim Y.S., Ng S.Y., Ling S.C. Deciphering lipid dysregulation in ALS: From mechanisms to translational medicine. Transl. Neurodegener. 2022;11:48. doi: 10.1186/s40035-022-00322-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00322-0</ArticleId><ArticleId IdType="pmc">PMC9641964</ArticleId><ArticleId IdType="pubmed">36345044</ArticleId></ArticleIdList></Reference><Reference><Citation>Odnoshivkina U.G., Kuznetsova E.A., Petrov A.M. 25-Hydroxycholesterol as a Signaling Molecule of the Nervous System. Biochemistry. 2022;87:524&#x2013;537. doi: 10.1134/S0006297922060049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297922060049</ArticleId><ArticleId IdType="pmc">PMC9201265</ArticleId><ArticleId IdType="pubmed">35790411</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Vejux A., Namsi A., Nury T., Moreau T., Lizard G. Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols. Front. Mol. Neurosci. 2018;11:12. doi: 10.3389/fnmol.2018.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00012</ArticleId><ArticleId IdType="pmc">PMC5797798</ArticleId><ArticleId IdType="pubmed">29445325</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Yu J., Sardi S.P., Shihabuddin L.S. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis. Sci. Rep. 2021;11:803. doi: 10.1038/s41598-020-80378-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80378-y</ArticleId><ArticleId IdType="pmc">PMC7804278</ArticleId><ArticleId IdType="pubmed">33436868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutner U.A., Shupik M.A., Maloshitskaya O.A., Sokolov S.A., Rezvykh A.P., Funikov S.Y., Lebedev A.T., Ustyugov A.A., Alessenko A.V. Changes in the Metabolism of Sphingoid Bases in the Brain and Spinal Cord of Transgenic FUS(1-359) Mice, a Model of Amyotrophic Lateral Sclerosis. Biochemistry. 2019;84:1166&#x2013;1176. doi: 10.1134/S0006297919100055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297919100055</ArticleId><ArticleId IdType="pubmed">31694512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Liang W., Huo D., Wang H., Wang Y., Cong C., Zhang C., Yan S., Gao M., Su X., et al. SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ. 2023;30:369&#x2013;382. doi: 10.1038/s41418-022-01089-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01089-7</ArticleId><ArticleId IdType="pmc">PMC9950139</ArticleId><ArticleId IdType="pubmed">36443440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhutdinova K.A., Kasimov M.R., Giniatullin A.R., Zakyrjanova G.F., Petrov A.M. 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: A possible role of NO and lipid rafts. Mol. Cell. Neurosci. 2018;88:308&#x2013;318. doi: 10.1016/j.mcn.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.03.006</ArticleId><ArticleId IdType="pubmed">29550246</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollrath J.T., Sechi A., Dreser A., Katona I., Wiemuth D., Vervoorts J., Dohmen M., Chandrasekar A., Prause J., Brauers E., et al. Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances. Cell Death Dis. 2014;5:e1290. doi: 10.1038/cddis.2014.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.243</ArticleId><ArticleId IdType="pmc">PMC4611717</ArticleId><ArticleId IdType="pubmed">24922074</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov A.M., Kravtsova V.V., Matchkov V.V., Vasiliev A.N., Zefirov A.L., Chibalin A.V., Heiny J.A., Krivoi I.I. Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse. Am. J. Physiol. Cell. Physiol. 2017;312:C627&#x2013;C637. doi: 10.1152/ajpcell.00365.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00365.2016</ArticleId><ArticleId IdType="pmc">PMC5451522</ArticleId><ArticleId IdType="pubmed">28274922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryndina I.G., Shalagina M.N., Sekunov A.V., Zefirov A.L., Petrov A.M. Clomipramine counteracts lipid raft disturbance due to short-term muscle disuse. Neurosci. Lett. 2018;664:1&#x2013;6. doi: 10.1016/j.neulet.2017.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.11.009</ArticleId><ArticleId IdType="pubmed">29126773</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B.J., Park K.H., Park M.H., Huang E.J., Kim S.H., Bae J.S., Jin H.K. Acid sphingomyelinase inhibition improves motor behavioral deficits and neuronal loss in an amyotrophic lateral sclerosis mouse model. BMB Rep. 2022;55:621&#x2013;626. doi: 10.5483/BMBRep.2022.55.12.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2022.55.12.142</ArticleId><ArticleId IdType="pmc">PMC9813424</ArticleId><ArticleId IdType="pubmed">36229415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryndina I.G., Shalagina M.N., Protopopov V.A., Sekunov A.V., Zefirov A.L., Zakirjanova G.F., Petrov A.M. Early Lipid Raft-Related Changes: Interplay between Unilateral Denervation and Hindlimb Suspension. Int. J. Mol. Sci. 2021;22:2239. doi: 10.3390/ijms22052239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052239</ArticleId><ArticleId IdType="pmc">PMC7956661</ArticleId><ArticleId IdType="pubmed">33668129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasimov M.R., Zakyrjanova G.F., Giniatullin A.R., Zefirov A.L., Petrov A.M. Similar oxysterols may lead to opposite effects on synaptic transmission: Olesoxime versus 5alpha-cholestan-3-one at the frog neuromuscular junction. Biochim. Biophys. Acta. 2016;1861:606&#x2013;616. doi: 10.1016/j.bbalip.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2016.04.010</ArticleId><ArticleId IdType="pubmed">27102612</ArticleId></ArticleIdList></Reference><Reference><Citation>West R.J.H., Briggs L., Perona Fjeldstad M., Ribchester R.R., Sweeney S.T. Sphingolipids regulate neuromuscular synapse structure and function in Drosophila. J. Comp. Neurol. 2018;526:1995&#x2013;2009. doi: 10.1002/cne.24466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24466</ArticleId><ArticleId IdType="pmc">PMC6175220</ArticleId><ArticleId IdType="pubmed">29761896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pato C., Stetzkowski-Marden F., Gaus K., Recouvreur M., Cartaud A., Cartaud J. Role of lipid rafts in agrin-elicited acetylcholine receptor clustering. Chem. Biol. Interact. 2008;175:64&#x2013;67. doi: 10.1016/j.cbi.2008.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2008.03.020</ArticleId><ArticleId IdType="pubmed">18485338</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivoi I.I., Petrov A.M. Cholesterol and the Safety Factor for Neuromuscular Transmission. Int. J. Mol. Sci. 2019;20:1046. doi: 10.3390/ijms20051046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20051046</ArticleId><ArticleId IdType="pmc">PMC6429197</ArticleId><ArticleId IdType="pubmed">30823359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil C., Soler-Jover A., Blasi J., Aguilera J. Synaptic proteins and SNARE complexes are localized in lipid rafts from rat brain synaptosomes. Biochem. Biophys. Res. Commun. 2005;329:117&#x2013;124. doi: 10.1016/j.bbrc.2005.01.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.01.111</ArticleId><ArticleId IdType="pubmed">15721282</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Martinez V., Montes M.A., Villanueva J., Gimenez-Molina Y., de Toledo G.A., Gutierrez L.M. Sphingomyelin derivatives increase the frequency of microvesicle and granule fusion in chromaffin cells. Neuroscience. 2015;295:117&#x2013;125. doi: 10.1016/j.neuroscience.2015.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.036</ArticleId><ArticleId IdType="pubmed">25813703</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J.Y., Lamer S., Schumann M., Schmidt M.R., Krause E., Haucke V. Quantitative proteomics analysis of detergent-resistant membranes from chemical synapses: Evidence for cholesterol as spatial organizer of synaptic vesicle cycling. Mol. Cell. Proteom. 2006;5:2060&#x2013;2071. doi: 10.1074/mcp.M600161-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M600161-MCP200</ArticleId><ArticleId IdType="pubmed">16861260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao H.T., Ryoo K., Lin A., Janoschka S.R., Augustine G.J., Porton B. Synapsins regulate brain-derived neurotrophic factor-mediated synaptic potentiation and axon elongation by acting on membrane rafts. Eur. J. Neurosci. 2017;45:1085&#x2013;1101. doi: 10.1111/ejn.13552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13552</ArticleId><ArticleId IdType="pmc">PMC5450799</ArticleId><ArticleId IdType="pubmed">28245069</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkova K., Christov A., Kamaluddin Z., Kobalka P., Siddiqui S., Hensley K. Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2014;73:702&#x2013;713. doi: 10.1097/NEN.0000000000000086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000086</ArticleId><ArticleId IdType="pmc">PMC4072440</ArticleId><ArticleId IdType="pubmed">24918638</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.M., Rafuse V.F. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1(G93A) mice. Neurobiol. Dis. 2020;145:105052. doi: 10.1016/j.nbd.2020.105052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105052</ArticleId><ArticleId IdType="pubmed">32827689</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E., Arbour D., Vallee J., Robitaille R. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1(G37R) ALS Mouse Model. J. Neurosci. 2020;40:7759&#x2013;7777. doi: 10.1523/JNEUROSCI.1748-18.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1748-18.2020</ArticleId><ArticleId IdType="pmc">PMC7531543</ArticleId><ArticleId IdType="pubmed">32859714</ArticleId></ArticleIdList></Reference><Reference><Citation>Adey B.N., Cooper-Knock J., Al Khleifat A., Fogh I., van Damme P., Corcia P., Couratier P., Hardiman O., McLaughlin R., Gotkine M., et al. Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival. Front. Cell. Neurosci. 2023;17:1112405. doi: 10.3389/fncel.2023.1112405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2023.1112405</ArticleId><ArticleId IdType="pmc">PMC10017967</ArticleId><ArticleId IdType="pubmed">36937187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Bai L., Li S., Wen Y., Liu Q., Li R., Liu Y. Simvastatin Enhances Muscle Regeneration Through Autophagic Defect-Mediated Inflammation and mTOR Activation in G93ASOD1 Mice. Mol. Neurobiol. 2021;58:1593&#x2013;1606. doi: 10.1007/s12035-020-02216-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02216-6</ArticleId><ArticleId IdType="pubmed">33222146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Zhang S., Kenna K.P., Moll T., Franklin J.P., Allen S., Nezhad H.G., Iacoangeli A., Yacovzada N.Y., Eitan C., et al. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell. Rep. 2021;34:108730. doi: 10.1016/j.celrep.2021.108730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108730</ArticleId><ArticleId IdType="pmc">PMC7856549</ArticleId><ArticleId IdType="pubmed">33535055</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukcharaeva E.A., Kim K.C., Moravec J., Nikolsky E.E., Vyskocil F. Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions. Pt 3J. Physiol. 1999;517:879&#x2013;888. doi: 10.1111/j.1469-7793.1999.0879s.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1999.0879s.x</ArticleId><ArticleId IdType="pmc">PMC2269380</ArticleId><ArticleId IdType="pubmed">10358126</ArticleId></ArticleIdList></Reference><Reference><Citation>Giniatullin A., Petrov A., Giniatullin R. Action of Hydrogen Peroxide on Synaptic Transmission at the Mouse Neuromuscular Junction. Neuroscience. 2019;399:135&#x2013;145. doi: 10.1016/j.neuroscience.2018.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.12.027</ArticleId><ArticleId IdType="pubmed">30593920</ArticleId></ArticleIdList></Reference><Reference><Citation>Glavinovic M.I. Voltage clamping of unparalysed cut rat diaphragm for study of transmitter release. J. Physiol. 1979;290:467&#x2013;480. doi: 10.1113/jphysiol.1979.sp012784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1979.sp012784</ArticleId><ArticleId IdType="pmc">PMC1278848</ArticleId><ArticleId IdType="pubmed">224172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharov A.V. Elph: An Open-Source Program for Acquisition Control and Analysis of Electrophysiological Signals. Uchenye Zap. Kazan. Univ. Seriya Estestv. Nauk. 2019;161:245&#x2013;254. doi: 10.26907/2542-064X.2019.2.245-254.</Citation><ArticleIdList><ArticleId IdType="doi">10.26907/2542-064X.2019.2.245-254</ArticleId></ArticleIdList></Reference><Reference><Citation>Margheri G., D&#x2019;Agostino R., Trigari S., Sottini S., Del Rosso M. The beta-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition. Lipids. 2014;49:203&#x2013;206. doi: 10.1007/s11745-013-3845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-013-3845-8</ArticleId><ArticleId IdType="pubmed">24122042</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks D.L., Bittman R., Pagano R.E. Use of Bodipy-labeled sphingolipid and cholesterol analogs to examine membrane microdomains in cells. Histochem. Cell. Biol. 2008;130:819&#x2013;832. doi: 10.1007/s00418-008-0509-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-008-0509-5</ArticleId><ArticleId IdType="pmc">PMC3922293</ArticleId><ArticleId IdType="pubmed">18820942</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoryev P.N., Khisamieva G.A., Zefirov A.L. Septin Polymerization Slows Synaptic Vesicle Recycling in Motor Nerve Endings. Acta Nat. 2019;11:54&#x2013;62. doi: 10.32607/20758251-2019-11-2-54-62.</Citation><ArticleIdList><ArticleId IdType="doi">10.32607/20758251-2019-11-2-54-62</ArticleId><ArticleId IdType="pmc">PMC6643342</ArticleId><ArticleId IdType="pubmed">31413880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhilyakov N., Arkhipov A., Malomouzh A., Samigullin D. Activation of Neuronal Nicotinic Receptors Inhibits Acetylcholine Release in the Neuromuscular Junction by Increasing Ca2+ Flux through Cav1 Channels. Int. J. Mol. Sci. 2021;22:9031. doi: 10.3390/ijms22169031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22169031</ArticleId><ArticleId IdType="pmc">PMC8396429</ArticleId><ArticleId IdType="pubmed">34445737</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>